These compounds differ in how they work, what they target, how long they stay active in the body, and what evidence exists to support their use
The concept is straightforward: combine the two most studied healing peptides at an optimal ratio so they work together
Hepatocellular injury, meaning damage to liver cells, releases stored vitamin B12 into the blood, and chronic liver disease reduces the clearance that normally keeps levels in check
What the evidence actually supports: Preclinical efficacy and reasonable safety at tested doses
It is similar to other injection vials
In recent years, a class of short peptides (often called bioregulators) has attracted interest in aging biology, neuroscience, and cellular health